Live Breaking News & Updates on Amo Pharma Limited

Stay updated with breaking news from Amo pharma limited. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

AMO Pharma Announces Completion of Treatment of Last Patient in Pivotal REACH-CDM Clinical Trial in Myotonic Dystrophy

/PRNewswire/ AMO Pharma Limited ("AMO Pharma"), a privately held biopharmaceutical company focusing on rare childhood-onset neurogenetic disorders with. ....

United Kingdom , New Zealand , City Of , Caitlin Oreilly , Ibs Mahmood , Nicholas Johnson , Virginia Commonwealth University School Of Medicine , Berry Company Public Relations , Commission On Human Medicines , Department Of Neurology , Pharma Limited , Drug Developers , Myotonic Dystrophy Foundation On , Chief Executive Officer , Virginia Commonwealth University School , Principal Investigator , Myotonic Dystrophy Foundation , Human Medicines , Amo Pharma Limited ,

AMO Pharma Announces MHRA Confirmation of CDM1-RS as Approvable Primary Outcome Measure in Myotonic Dystrophy

/PRNewswire/ AMO Pharma Limited ("AMO Pharma"), a privately held biopharmaceutical company focusing on rare childhood-onset neurogenetic disorders with. ....

United Kingdom , City Of , Kaitlin Gallagher , Peter Ashley , Nicholas Johnson , Ibraheem Mahmood , Pharma Limited , Drug Administration , Toxicology Centre , Regulatory Agency , National Health Service , Development Profile , National Institute For Health , Commission On Human Medicines , University Of Rochester , Myotonic Dystrophy Health Index , Berry Company Public Relations , Scottish Medicines Consortium , United Kingdom Medicines , Professor Chad Heatwole , Professor Nicholas Johnson , Innovation Passport , Innovative Licensing , Access Pathway , National Institute , Care Excellence ,

AMO Pharma Announces Completion of Enrollment in REACH-CDM Study in Congenital Myotonic Dystrophy

/PRNewswire/ AMO Pharma Limited ("AMO Pharma"), a privately held biopharmaceutical company focusing on rare childhood-onset neurogenetic disorders with. ....

City Of , United Kingdom , Ibs Mahmood , Joseph Horrigan , Bill Berry , Pharma Limited , Berry Company Public Relations , Chief Medical Officer , Chief Executive Officer , Amo Pharma Limited ,

AMO Pharma Announces Additional Private Equity Investment Following Progress in Phase 3 Study in Congenital Myotonic Dystrophy

/PRNewswire/ AMO Pharma Limited ("AMO Pharma"), a privately held biopharmaceutical company focusing on rare childhood-onset neurogenetic disorders with. ....

New Zealand , City Of , United Kingdom , Joseph Horrigan , Bill Berry , Pharma Limited , Berry Company Public Relations , Chief Medical Officer , Amo Pharma Limited ,

Julia Jones Joins AMO Pharma As Chief Financial Officer And Board Member

/PRNewswire/ AMO Pharma Limited ("AMO Pharma"), a privately held biopharmaceutical company focusing on rare, childhood-onset neurogenetic disorders with. ....

City Of , United Kingdom , Martyn Williams , Julia Jones , Bill Berry , Ibraheem Mahmood , Pharma Limited , Berry Company Public Relations , Loughborough University , Archangel Accounting Ltd , United Kingdom Based , Amo Pharma Limited , Health Care Amp Hospitals , Medical Pharmaceuticals , Biotechnology , Pharmaceuticals , Personnel Announcements ,